JPRN-UMIN000044830
Completed
未知
Retrospective Cohort Study of immune checkpoint inhibitor - Retrospective Cohort Study of immune checkpoint inhibitor
ConditionsCancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Juntendo University Hospital
- Enrollment
- 700
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who are judged as being inappropriate for this study by their medical doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A prospective observational study of immune-checkpoint inhibitor (Nivolumab) treatment in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000021600Kitasato University School of Medicine52
Completed
Not Applicable
An exploratory biomarker study of immunecheckpoint inhibitors using tumor tissue and peripheral bloodlung cancer, and melanomaJPRN-UMIN000024414Wakayama Medical University120
Recruiting
Not Applicable
Cohort study of immune-checkpoint-inhibitor antibody treatment in non-small-cell lung cancernon-small-cell lung cancerJPRN-UMIN000020719Saitama Medical University International Medical Center100
Completed
Not Applicable
A prospective observational study of immune-related adverse events, treatment efficacy, and pre-existing autoantibodies in patients with small-cell lung cancer who was treated by immune checkpoint inhibitorPatients with small cell lung cancer who was treated by chemotherapy plus immune checkpoint inhibitor as first line therapyJPRN-UMIN000042962Kobe City Medical Center General Hospital Respiratory Medicine54
Active, not recruiting
Phase 2
A study to investigate if atezolizumab can reduce the size of urothelial cancer before surgery and to determine how the drug worksISRCTN22771691Queen Mary University of London58